CAMDEN HELDER: Open Payments
NPI 1366933046 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,488 in 128 payments from 19 companies in 2025. Trend: 2023 $575 · 2024 $1,551 · 2025 $2,488
Food & beverage: $2,483Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $382 |
| Neurocrine BioSciences, Inc. | 16 | $380 |
| E.R. Squibb & Sons, L.L.C. | 12 | $250 |
| Janssen Pharmaceuticals, Inc | 16 | $231 |
| Alkermes, Inc. | 11 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $122 |
| Vanda Pharmaceuticals Inc. | 5 | $117 |
| Corium, LLC | 6 | $115 |
| Tris Pharma Inc | 6 | $113 |
| Axsome Therapeutics, Inc. | 5 | $113 |
Products named: INGREZZA, VRAYLAR, COBENFY, ARISTADA, SPRAVATO, CAPLYTA, FANAPT, Azstarys.
Industry payments across GA — which companies pay providers there.
